SMOLTEK NANOTECH HLDG AB

Smoltek reported no material revenues in Q3 2025 and instead emphasized an investment and development phase focused on semiconductor and hydrogen technologies. The company had 18.5 million SEK in cash at the end of September and reported cost reductions versus prior periods. Key partnerships were formed with ITRI in Taiwan and Heraeus Precious Metals; Smoltek is also exploring grant opportunities under the EU Chip Act and aims to complete first-generation products by year-end. The stock slipped slightly, reflecting investor caution given the technology is not yet commercialized. » Altro su de.investing.com